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Abstract
Background: Much money and energy has been spent on the study of the molecular biology of
malignant brain tumours. However, little attention has been paid to the wishes of patients afflicted
with these incurable tumours, and how this might influence treatment considerations.
Methods: We interviewed 29 individuals – 7 patients dying of a malignant brain tumor and 22
loved ones. One-on-one interviews were conducted according to a pre-designed interview guide.
A combination of open-ended questions, as well as clinical scenarios was presented to participants
in order to understand what is meaningful and valuable to them when determining treatment
options and management approaches. The results were analyzed, coded, and interpreted using
qualitative analytic techniques in order to arrive at several common overarching themes.
Results: Seven major themes were identified. In general, respondents were united in viewing brain
cancer as unique amongst malignancies, due in large part to the premium placed on mental
competence and cognitive functioning. Importantly, participants found their experiences, however
difficult, led to the discovery of inner strength and resilience. Responses were usually framed within
an interpersonal context, and participants were generally grateful for the opportunity to speak
about their experiences. Attitudes towards religion, spirituality, and euthanasia were also probed.
Conclusion: Several important themes underlie the experiences of brain cancer patients and their
caregivers. It is important to consider these when managing these patients and to respect not only
their autonomy but also the complex interpersonal toll that a malignant diagnosis can have.
Background
The issue of the psychological state of the dying has
received significant attention in the medical literature [1-
9]. Most research has focused on questions surrounding
physician assisted suicide, and recently, the increasing
awareness of spiritual and existential factors that can con-
tribute to psychological, and physical well-being at the
end of life [1,2,10-15]. Although questionnaires and sur-
veys assessing these factors have been validated in various
palliative populations [3,16,17], they often fail to capture
the subjective experience of dying in these patients. For
this reason, patient interviews might provide the best
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opportunity to explore these sensitive issues in a way that
respects the diversity of the illness experience [18-21].
Such a qualitative analytical approach can be used to
understand and capture the dynamic state of mind of the
dying patient. The purpose of the present investigation
was to explore what is meaningful to individuals dying of
terminal brain cancer. Questions surrounding the costs
and benefits of various treatment options were discussed
in one-on-one interviews in order to gain insight into the
factors considered important in the lives of these patients.
The consequences of a cancer diagnosis are far-reaching
and complex, affecting not only the patient but his/her
network of caregivers as well. Several studies have demon-
strated the toll that a cancer diagnosis has on families of
patients, and the importance of communication both
within families and between health care providers and
caregivers [22,23]. Treatment decisions are frequently
group decisions, made with the underlying assumption
that treatment for one may have implications for many.
The value of the caregiver's perspective therefore becomes
that much more important, and to accurately gauge atti-
tudes towards treatment and dying, these need to be taken
into account. Some studies in the literature have begun to
consider caregiver attitudes and these have added signifi-
cant weight to interpretations of the decision making
process in terminally ill patients [19,24,25].
Among the malignant diseases, brain cancer is unique in
that the organ affected is traditionally viewed as the seat
of an individual's literal sense of identity. Philosophical
enquiries regarding the manifestation of behaviour and
the cognizance of one's existence all involve the brain, an
organ around which many more questions exist than
answers. As a result, studying these patients' responses
and experiences with an illness that threatens their exist-
ence is conceptually and practically appropriate. Although
few studies have investigated brain cancer populations
specifically, some studies have explored coping and the
meaning of illness in advanced cancer patients [1,2,4,20].
For example, in some mixed palliative populations stud-
ied, hopelessness and desire for death have been linked to
physical distress in addition to psychiatric depression
[3,8]. Measures have also been devised assessing and
measuring meaning and the will to live [15], in addition
to the desire to die [7,16,17,26] in these patients, how-
ever, investigators rarely, if ever, discuss cancer type as an
independent variable. Such studies attempt to gauge atti-
tudes towards death, but do not necessarily examine what
these patients value in life.
Cancer of the brain, though relatively rare, is most fre-
quently fatal [27]. The devastating consequences of the
disease for patients, families, and caregivers necessitate
further exploration in the domain of subjective illness
experience and therapeutic decision making [28]. It is
therefore important that both investigators and clinicians
acquire a better understanding of what is meaningful and
valuable to individuals living with terminal brain cancer.
Such an understanding, guided by an analysis of the
patient's and caregiver's concerns, wishes and beliefs,
would contribute significantly to current models of thera-
peutic management and developing relevant goals in clin-
ical trials for these patients. The objective of our study,
therefore, is to examine the illness experience of caregivers
and patients living with brain cancer, and to see how
those experiences colour attitudes towards treatment.
These issues have yet to be explored in this patient popu-
lation and this study can potentially aid in their compre-
hensive management.
Methods
Design
The present study was a qualitative case study utilizing
face-to-face one-on-one interviews with terminally ill
patients and/or their caregivers.
Setting and participants
Participants in the study were patients with known termi-
nal brain cancer. Where patients could not be interviewed,
caregivers and family members were substituted. Patients
and families were selected by a senior staff neurosurgeon
(MB) and informed consent was obtained from all partic-
ipants. The study rationale and objectives were compre-
hensively discussed. Patients with the diagnosis of
glioblastoma or metastatic brain cancer were selected and
the following exclusion criteria were used: 1) those who
were not cognitively intact; 2) those who could not ade-
quately communicate in English; and 3) those felt to be
too psychologically fragile to participate. The same inclu-
sion criteria were used to screen caregivers and family
members participating in the study.
Sample size
Twenty-nine (29) participants were sought for interviews,
and this included twenty-two caregivers and seven
patients. The sample size is similar to previous qualitative
studies done with surgical patients [29]. Further, it was felt
that the sample size was adequate to reach a sufficient
level of "saturation", a term describing a point beyond
which no new concepts will arise as a result of further
interviews [30]. Also, given the effect of the disease on the
caregiver perspective, it was not seen as deleterious to the
rigor of the study that the majority of interviews were con-
ducted with close family members.
Data collection
This study took place in a tertiary care, teaching hospital,
functioning within a socialized medical system. Inter-
views, which ranged in length between 45 minutes andBMC Palliative Care 2007, 6:7 http://www.biomedcentral.com/1472-684X/6/7
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one hour, were conducted over a period of 12 months.
Various aspects of the illness experience were explored,
including the role of faith and spirituality, attitudes
towards euthanasia and the value of such discussions.
Interviews were based on an interview guide (Figure 1),
but enough latitude was left to allow the interviewer a
chance to explore potentially insightful avenues. The
guide was designed by the research team, and continually
refined, according to the study's overall objectives. Scenar-
ios contained within the interview guide were strictly
hypothetical, although addressed issues that neurosurgi-
cal patients are routinely confronted with. Our goal was to
examine the treatment decision-making and risk evalua-
tion process in this specific population. A trained research
assistant conducted all the interviews. All interviews were
audiotaped and transcribed, and demographic informa-
tion about each patient and caregiver was collected.
Data analysis
Data were analyzed using modified thematic analysis
techniques which included open and axial coding phases
[30]. In open coding, data was analyzed and broken down
into common groupings based on shared ideas, whereas
with axial coding, data was classified according to over-
arching themes. A computer program was not used for the
analysis. Four persons independently participated in the
analysis of interview transcripts and in the development
of the coding framework. Researchers fractured interview
responses and results into ideas and coalesced these into
overarching, general themes. Once data was analyzed and
interpreted, it was clear that our sample size was sufficient
since saturation appeared to have been reached, and no
new themes emerged from further analysis.
Interview Guide Figure 1
Interview Guide.
The purpose of this study is to examine what is important and meaningful in the lives of individuals living with brain cancer. Meaning is 
something that means different things to different people, but what we want to discover is what factors you take into consideration, when you are 
deciding to go ahead with some treatment. Asking these questions allows researchers and doctors to learn more about the illness experience and 
to understand what is important to patients when they design future treatments. For example, surgeons might want to know if a patient would 
agree to be partially paralyzed as a result of a new treatment in exchange for prolonging their survival for a few months. Answers to questions 
like this tell doctors what their patients’ value and allows them to tailor treatments to the interests and wishes of their patients. Each person is 
unique, and each person’s beliefs about their life and disease are different, so there are no right or wrong answers to these questions. Your 
privacy, of course, will be maintained and no one will be able to know how you answered these questions. 
Questions 
1.  Do you have any questions about any of this?  
2.  What aspect of your life has been most affected by your diagnosis? This can be anything from physical ability or memory to personal 
relationships. 
3.  Have you ever thought about what having brain cancer means to you? For example, do you think having cancer of the brain is different 
in some way than having a different kind of cancer, like lung cancer? Tell me more. 
4.  What sorts of things do you take into account when your doctor discusses possible treatments with you? These could be things you may 
consider important in your life such as occupation, family, self-image, recreation etc. 
5.  I’m going to run through a few scenarios now, and I want you to tell me which choice you would go with, and also why you chose as 
you did. Would you agree to: 
a.  Surgery to prolong survival for 3 months, but leaving paralyzed half of your body. 
b.  Treatment to prolong survival for 6 months, but with memory severely impaired. 
c.  Surgery to prolong survival for 1 year, but leaving your body completely paralyzed. 
i.  Do you foresee any risk or cost that would make you not want to go ahead with treatment? 
ii.  How many months/years of survival would you accept to agree to these consequences? 
6.  Do spiritual or religious beliefs help you cope with what has happened to you? 
7.  Has having this disease taught you anything new about yourself that you never knew before? For example, sometimes when people are 
diagnosed with certain diseases, they examine their life and reach some conclusions about themselves, those around them, their 
surroundings etc. Have you gone through a similar process? Please tell me more. 
8.  What are your opinions about euthanasia? Please tell me more. 
9.  As the final question, I just wanted to get a sense of what your thoughts are about this interview. Do you think studies like this are 
important? Do you have any questions, or thoughts you’d like to share at this point?  BMC Palliative Care 2007, 6:7 http://www.biomedcentral.com/1472-684X/6/7
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Research ethics
Participation in this study was voluntary and all informa-
tion gathered, including demographics and patient partic-
ipation, was kept confidential. The study was initially
introduced by the treating neurosurgeon, and the details
of the study were discussed at a separate time by different
members of the research team. Informed consent was
obtained at that time by the research assistant who also
conducted the interviews. Interview audiotapes and tran-
scripts were anonymously labeled and secured. The
Research Ethics Board of the University Health Network
approved the study.
Results
Participant information
Patient and caregiver demographic data are summarized
in Table 1.
Thematic analysis
Several themes emerged from the interviews. Caregivers
were frequently more forthcoming and reflective than
patients, and presumably viewed the interview session as
an opportunity to explore these personal issues. The
major themes identified shed much light on the experi-
ences of caregivers and patients, and their attitudes are
quite informative in the context of a terminal illness
affecting the brain. The following is a description of these
themes illustrated with verbatim quotes.
Brain cancer is unique
There appeared to be a relative consensus amongst the
study participants that even when compared with the
other malignant diseases, brain cancer is unique. Usually,
the focus was on the brain as a control center, and the seat
of the literal sense of identity, as well as memory and con-
centration.
"I would probably be concerned about losing the things that
make me who I am."
"...the brain is the big center of everything...."
In addition to finding brain cancer unique, this was usu-
ally, but not always interpreted in a negative fashion. For
example, the rapidity of the intellectual and physical
decline, the lack of any effective and long-lasting treat-
ments, and the grimness of the diagnosis were all cited as
distinguishing negative features of the disease. Some indi-
viduals, however, mentioned cognitive decline, memory
loss and the relative lack of pain as positive features of the
disease that, in effect, spared their loved ones of the
awareness of suffering.
"In some ways it's better... [the patient] did not realize what
was really happening to him."
These examples speak to the tremendous variation in
patient and caregiver experiences. A devastating symptom
for one patient, may indeed be a redeeming feature for
another patient, or at least provide some emotional or
psychological comfort.
Most participants implicitly understood that diseases of
the brain are in fundamental ways different than diseases
of other organ systems. Frequently, the sentiment was
echoed that each brain cancer is unique, whereas other
cancers are largely alike.
"If you have lung cancer...your symptoms are usually pretty
similar to the other guy that has lung cancer."
"You can remove a breast and you can still function, or you can
still work with one lung, and this just seems like its all or noth-
ing."
Perhaps the most powerful, and moving, indictment of
the disease came from one participant, who when asked if
they could articulate how brain cancer may be different
from other cancers, responded:
"It's not just a diagnosis, it's almost like it's a sentence on all
the other aspects of his life."
Table 1: Participant Demographics (N = 29)
Age 45.5 (mean)
Sex Male 8 (27.6)*
Female 21 (72.4)
Marital status Single 4 (13.8)
Married 20 (70)
Divorced 3 (10.3)
Widowed 2 (6.9)
Education Secondary 4 (13.8)
University/College 21 (72.4)
Post-graduate 4 (13.8)
Religion None 2 (6.9)
Hindu 1 (3.4)
Roman Catholic 12 (41.4)
Anglican 3 (10.3)
Christian 2(6.9)
Jewish 2(6.9)
Sikh 1 (3.4)
Muslim 1 (3.4)
Protestant 3 (10.3)
Lutheran 1 (3.4)
Non-religious but spiritual 1 (3.4)
*Numbers in brackets represent percentages of total.BMC Palliative Care 2007, 6:7 http://www.biomedcentral.com/1472-684X/6/7
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Although several subjects provided the proviso that malig-
nant diseases are terrifying despite the organ involved,
there nevertheless remained an overall understanding
amongst nearly all participants, that brain cancer is some-
how unique and in a category all unto its own.
Lessons are derived from experiences
Most participants were able to describe lessons that they
have learned as a result of dealing and coping with a ter-
minal illness. Some caregivers framed their experiences as
challenges or opportunities to learn and grow.
" [The illness experience] Taught me how to face adversity and
not feel sorry for myself, and just fight and be strong, and it just
gave me a good example."
" [I've learned] I can cope with this, I can deal with this, and
in a way that's been empowering for me...I've had to rise to the
challenge."
The rapidity of the illness resulted in some patients and
caregivers having to significantly adjust their lives and
their schedules over a short period of time. Obligations
that didn't exist previously, now took precedence, and
participants found that they learned to prioritize, and
focus on family, and home life.
"I think my life has slowed down back to a point where I can
just go through life and enjoy every moment."
The idea of strength emerged as particularly important, as
several patients reported surprise at the amount of emo-
tional and psychological fortitude they possessed when
dealing with difficult situations.
"I always knew I had strength and that people can lean on me,
and it just emphasized that even more."
Again, individual experiences are varied, and not all
patients derived lessons from their illnesses. Whether due
to pre-existing coping mechanisms or individual person-
alities, some caregivers and patients approached the dis-
ease in unique ways. One caregiver, referring to how he
and his wife make decisions regarding treatment, com-
mented:
"We tend to make decisions [when] we have as much informa-
tion as we can...whether that's the purchase of a TV or dealing
with brain cancer."
Quality of life is very important
One of the most consistent themes that emerged during
the interviews was the notion that quality of life, the
make-up of which varied between patients, was more
important than prolongation of life.
"Quality is more important than quantity."
During the interviews, the authors attempted to gauge
attitudes towards quality of life through various scenarios.
These included selecting between surgery that would pro-
long life by 3 months but would result in hemiparesis, or
surgery for survival of 12 months but that would result in
quadraparesis. Patients overwhelmingly selected the 3
month option, citing the importance of quality of life,
both for the patient and caregiver.
"I would choose normal function for less time, without any
question."
An additional theme identified, which will be discussed in
more detail below, dealt with the premium that patients
placed on mental competence. Quality of life was fre-
quently framed in terms of whether an individual patient
would be a 'vegetable', or be able to think or maintain
awareness. In most instances, participants made it clear
that such an existence would be inconsistent with a high
quality of life, and elected to hypothetically and in some
cases, literally, refrain from obtaining additional treat-
ment.
"He wouldn't want to be around for the sake of just being
around."
"If there's no quality of life, then neither one of us wants to be
alive."
Spirituality is often helpful
A majority of caregivers interviewed expressed that spirit-
ual, but not necessarily religious, beliefs were able to pro-
vide them with comfort and additional strength to cope
with their illness.
"I'm not a practicing Catholic...I think it's more a spiritual
sense."
In contrast to caregivers, few patients were able to articu-
late how religion plays a part in their coping, although
some referred to the feelings of connectedness between
individuals, and the overall sense of the role that even ill-
ness has in a larger, potentially divine, plan.
"We believe we're all connected and that there's, a reason for
this. This is part of life and everybody has something that they
deal with from time to time and this just happens to be ours."
Whether representing a means to adapt to a difficult situ-
ation, or a continued pattern of previous observance, it
did not appear that religion or spirituality affected treat-
ment choices or how aggressive patients or caregivers were
with their illness. In most respects, spirituality was seenBMC Palliative Care 2007, 6:7 http://www.biomedcentral.com/1472-684X/6/7
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more as a means towards understanding, rather than guid-
ance.
"The soul never dies. The body is just like the jacket you are
putting on."
No matter what their roles, or the participants' particular
willingness to discuss them, spiritual and/or religious
beliefs were common in the majority of individuals inter-
viewed, and were in large part seen as a positive part of
their experience.
Mental competence is paramount
Although the interviews made clear that participants
placed a premium on quality, as opposed to quantity, of
life, the definition of quality can and does vary in the
larger population. We discovered that the patients and
caregivers interviewed often felt it necessary, particularly
when faced with a terminal disease of the brain, to
emphasize the importance of mental functioning, orienta-
tion and cognition in their definitions of quality of life.
The prospect of memory loss and intellectual decline, in
most cases, proved to be the most common reason that
participants cited to shorten life by declining additional
treatment.
"When you don't have the cognitive ability...I think that's
where she draws the line."
"The fact that his mental functioning is intact is really...the
most importance piece."
This emphasis on mental capacity, again, drew attention
to the unique experiences of brain cancer patients, even
among the other aggressively malignant diseases. Patients
and families understood that a disease affecting the brain,
and in essence, the mind, was qualitatively different than
diseases of other organs.
"It's another thing not being able to remember who you are or
who I am. You know, that to me is different."
"He always said he would prefer to lose a limb than to have his
mind go."
An additional, and valuable, perspective was gained on
caregiver priorities as well, with disabilities of the body
seen as far easier to manage than disabilities of the mind.
Caregivers consistently commented that to lose their
loved one's identity, memory and awareness would be
tantamount to their dying, and that the loss of independ-
ence and vitality in a previously very high functioning
individual would be psychologically and emotionally
traumatic.
"As long as his mind is there...we could go on forever."
"I don't want it to affect his brain, that's the thing...paralyzed
I can handle." 
In keeping with the trend of variations in experience, not
all patients viewed intellectual and cognitive deterioration
as necessarily negative, with at least one caregiver report-
ing that a blunted affect would aid the patient to not expe-
rience the emotional consequences of dying.
"I find the hardest things now is for her to feel the emotional
pain, whereas if she had no memory she wouldn't have the emo-
tional worry."
Attitudes towards euthanasia vary
Consistent with the contentious nature of this issue, our
interviews did not point to a resounding consensus with
regards to access to physician assisted suicide and eutha-
nasia. However, although patients and caregivers were not
united with respect to the means or the regulation of the
practice, there was general agreement that the decision
should ultimately be in the hands of the patient and fam-
ily.
"...quality of life is important and I think when people think
they've had enough, that that should be respected."
Most caregivers when asked directly supported the idea of
euthanasia. They usually framed their responses in terms
of quality of life and emphasized that withdrawal of care,
for example, would be justified if the circumstances were
grim. Some individuals, however, reported feeling
uncomfortable with the idea of euthanasia, even in
extreme cases. Others appealed to higher power.
"It may be right for some people and in some extreme cases...but
for me personally I don't think I have the right, either for myself
or for somebody else, to do that."
"That's something that God decides."
Talking is helpful
Both patients and their loved ones were generally grateful
for the opportunity to speak to a member of the health
care team about these personal and distressing issues.
Existential concerns are not typically broached in a clini-
cal setting outside of palliative care wards, and caregivers
especially commented that such studies will hopefully
encourage health care workers to pay more individual
attention to terminally ill patients.
" [It's important] for people to try to understand what people
are going through. I think it's just as important as the medical
treatment."BMC Palliative Care 2007, 6:7 http://www.biomedcentral.com/1472-684X/6/7
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In more than one instance, an interview transcript could
have been interpreted as a cathartic experience for a car-
egiver, who had been coping with a dying loved one and
who viewed the opportunity to speak openly as almost
therapeutic. Such interviews allowed them to reframe
their experiences, and articulate to the medical world at
large the importance of family centered care, and the
uniqueness of the patient experience.
"When you're dealing with a terminal illness, it's not just about
treating the patient but it's also about making things easier for
the surviving family."
"I think it's extremely important. It helps people understand, if
they have to go through it, to understand their feelings."
At the end of each interview, participants were asked what
they thought of such studies and whether they perceived
them as valuable. Only one patient, out of twenty nine
participants did not see the potential utility of the study,
but was able to understand and agree with it after it was
explained to him in more practical terms. The overwhelm-
ing majority of patients viewed the interview as not only
helpful but necessary, particularly in a health care climate
that they perceived as more focused on the bottom line
than helping individual patients.
"There is still someone who cares enough to ask about a family
or a patient in a society where everything is governed by a
budget."
"That's the thing about this study, is that somebody actually
cares about my dad."
Summary of themes
In order to facilitate the interpretation of the themes iden-
tified we created a coding framework that allowed us to
further analyze the attitudes of respondents to each of the
themes. When a caregiver or patient expressed strong feel-
ings in favour of a given theme, such as that quality of life
was extremely important, the value of +2 was assigned.
When the feelings were milder, +1 was assigned and if
feelings were completely neutral, a value of 0 was given.
Similarly, when participants expressed strong feelings
against a given theme, for example strongly believing that
brain cancer was not unique, the value of -2 was assigned,
and lighter negative feelings received -1.
Such a coding framework allowed us to understand the
intensity with which participants viewed each theme, and
highlighted in a novel way, the direction of the attitudes
towards the illness experience. The results appear in Figure
2 and include the proportion of respondents who
expressed favourable, opposing, or neutral thoughts
towards each of the aforementioned themes. Several inter-
esting points can be identified. Firstly, patients almost
universally valued quality of life versus life prolongation
when making treatment decisions. They also overwhelm-
ingly perceived the interview experience to be not only
beneficial but therapeutic, and saw such studies as poten-
tially helpful for the development of comprehensive man-
agement of terminally ill patients. Respondents appeared
to be relatively polarized with respect to the role of spirit-
uality and religion, with few expressing neutral opinions,
and nearly 70% finding solace in religious beliefs while
30% finding religion to not be helpful. Predictably, eutha-
nasia proved to be the most contentious issue; however,
relatively few expressed strong negative feelings towards
it, with several participants justifying the action based on
dwindling quality of life.
Discussion
The aim of this study was to examine the values and atti-
tudes of patients and their caregivers towards their experi-
ence with terminal brain cancer, and whether these
influenced their treatment decisions. Our brains, and
minds, differentiate us not only from other animals, but
also from each other, and the opportunity to study the
Summary of Attitudes Figure 2
Summary of Attitudes. Graph illustrating the attitudes of 
patients and caregivers towards the seven identified themes. 
Attitudes were deemed to be in favour if they received a 
positive score (+2 or +1) according to our coding frame-
work. Attitudes opposed were those that received negative 
scores (-2 or -1). A neutral score (0) was obtained if the par-
ticipant was undecided, or if a question was not asked. Leg-
end: Uniqueness – Brain Cancer is Unique; Strength – personal 
strength or lessons are derived from the illness experiences; 
Quality of Life – quality of life is more important than prolon-
gation of life; Euthanasia – general attitude towards euthana-
sia; Religion – spirituality and/or religion play a role in coping 
with the illness; Mental Competence – a premium is placed on 
cognition, memory and mental competence over motor func-
tioning; Talking – it is helpful to talk about the illness experi-
ence, and such studies are important.
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unique experiences of brain cancer patients is an opportu-
nity that should not be missed.
A study examining the value of speaking to terminally ill
patients about death and dying illustrated that such dis-
cussions are not only devoid of stress for participants but
indeed are helpful [19]. In this study, approximately 50%
of both patients and caregivers found discussions related
to death and dying helpful and only less than 10% of
patients, and less than 25% of caregivers reported the
interview as stressful. Clearly such discussions, which pro-
mote communication both between patients and the
health care team and among families are important, and
should be taking place. Given the relative rapidity of the
decline in many brain cancer patients, an argument can be
made that the opportunities for discussion are fewer and
hence, more urgent, in these patients, whose life has been
drastically changed over so little time.
The novel aspects of the study here focused on the patient
population and the application of qualitative analytic
research methods. Recently, qualitative analysis was used
in a palliative care setting to assess the attitudes of seven
patients with terminal cancer who expressed a desire for
hastened death [31]. The themes identified by that study
echo some of our own, with patients focusing on the
importance of a social support network and the derivation
of life lessons and strength from their disease. The authors
did not differentiate the patients according to cancer type,
and so it us unknown whether any were suffering from
brain cancer.
The themes we identified speak to the concerns and
unique experiences of brain cancer patients. As with other
malignancies, there are lessons to be learned from the
unique aspects of organ specific diseases. For example, the
association of breast resection with feelings of loss of fem-
ininity [32,33] may be viewed as analogous to the loss of
cognitive functioning and identity seen with brain cancer.
The fact that patients independently identify the differ-
ences between brain cancer and other malignancies rein-
forces the unique needs of patients suffering from an
illness that affects their organ of self-identity and mind.
The finding that most patients and caregivers derived
strength from their experiences is a testament to their
resilience in the face of significant adversity. We believe
that this resilience is more common than believed, and
should be assumed when discussing diagnosis and treat-
ment with patients and caregivers. However, as will be dis-
cussed below, there is an inherent selection bias in studies
such as ours whereby emotionally stronger patients and
caregivers may be more willing to discuss these difficult
issues. This is a bias that is common to most research in
palliative and chronic care [19,34].
An additional important pattern that emerged when
patient and caregiver interviews were analyzed was that
responses were frequently framed with respect to others,
be they other caregivers, family members, or the patients'
themselves. Interestingly, this pattern appeared to be
common to all the themes identified; for example atti-
tudes towards euthanasia and quality of life were fre-
quently expressed in terms of what was best for others,
rather than for the individual answering. This pattern
underscores the complex interpersonal dynamic of the ill-
ness experiences, illustrating that decisions, and diag-
noses, do not exist in vacuums, and that numerous people
can be affected.
Clinical relevance and recommendations
Our findings have direct clinical implications. Clinicians
and health care providers, from neurosurgeons to ward
nurses to social workers, all come into contact with
patients with malignant disease, and eventually with
patients with brain cancer. It is vitally important to under-
stand the mindset of these patients and their caregivers in
order to provide them with comprehensive and effective
care. The themes identified here should provide a starting
point from which fruitful discussions of the patient expe-
rience may begin, and on which treatment and manage-
ment decisions can be premised. We have summarized
our findings in the form of several recommendations in
Figure 3. These recommendations serve to raise the con-
sciousness of health care providers to these important
issues.
Clinicians should first acknowledge the uniqueness of the
disease. Patients and caregivers should have their con-
cerns regarding personality change and cognitive decline
validated, and it should be noted that these concerns are
unique to brain cancer and that additional supports are
available as needed. To this end, clinicians should arrange
social work consultations for patients who they believe
require additional assistance with dealing with the social
consequences of their disease. In some cases a referral to
psychology, or psychiatry, may be necessary.
Although religious and spiritual beliefs are common and
varied, the clinician should not feel obligated to discuss
these at great length. At the discretion of the individual
physician, an acknowledgment of the consolation that
religion can provide some patients may be helpful, and
deepen the therapeutic alliance.
Perhaps most importantly, our study has demonstrated
the importance of assessing patients' values and priorities
with regards to treatment. Some patients place a premium
on cognitive versus physical abilities, and will forego
treatment that will spare motor activity but will risk mem-
ory or personality, for example. Other patients will chooseBMC Palliative Care 2007, 6:7 http://www.biomedcentral.com/1472-684X/6/7
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the opposite. The nature of quality of life, therefore, is
diverse and should be respected. The importance lies in
asking patients what is important to them.
Limitations of the study
Our study has several limitations. As alluded to earlier,
there exists a selection bias, whereby only patients and
loved ones who are strong enough emotionally and psy-
chologically to discuss these personal issues will partici-
pate. Patients and caregivers who may not have come to
terms with their diagnosis, or who are having a particu-
larly difficult time dealing with their illness may be too
distraught to participate. These patients are also arguably
the most interesting, as the reasons for a failure to cope are
sometimes more informative than an individual person's
coping mechanism. Furthermore it would have been pref-
erable to have more actual patients but this was challeng-
ing for obvious reasons.
Another weakness lies in our potentially limited represen-
tation of patient experiences. Although some studies have
discussed the use of proxy substitutes to assess patient
concerns and beliefs [35,36], there remains no real substi-
tute for the patient's own words. Brain cancer, as we
hoped to illustrate, is an intensely interpersonal disease
that places both patients and caregivers in unique posi-
tions. One can argue, as we have, that the illness experi-
ence cannot be understood without examining both the
patient and family perspectives, given the rapidity of the
decline and the all-encompassing clinical nature of the
disease. Nevertheless, we hope that future research will
involve greater numbers of patients and will supplement
the findings of the present study.
Further, since we designed the interview guideline, there
exists the possibility that the best questions were not
asked and that particular avenues were not explored,
although the interview guide may (and did in this study)
evolve over time.
The aim of this investigation, which was designed as a
pilot study, was to describe our patients' and their loved
ones' experiences with their illness rather than to arrive at
broad, generalizable conclusions about those experiences.
Our study naturally has several extensions that would
enrich the results obtained here. Future studies can com-
pare the themes discovered here to those obtained in
other terminally ill patient populations, such as those
dying of breast, or lung cancer. Furthermore, each of the
themes obtained could suitably be used as a springboard
for further investigation, for example, exploring in greater
detail the psychological growth and lessons learned from
coping with a terminal diagnosis. We hope that the issues
and themes raised can stimulate further research in this
important area.
Conclusion
The importance of existential issues in terminally ill
patients should not be underestimated. This importance,
furthermore, is heightened in patients with advanced
brain cancer, a disease that may affect the capacities that
make patients unique, such as their personality and mem-
ory. We have identified several underlying themes in the
illness experience of patients and caregivers that could
serve as platforms on which discussions, such as those sur-
rounding treatment, can be based. To address these issues
and to keep them at the forefront of one's mind, would
enrich the clinical experience and ensure that the patient
and caregiver perspective is always respected. Arguably,
our most important finding is that patients and their
loved ones value the opportunity to engage in discussions
about these delicate and sensitive issues as they approach
the end of their life.
Recommendations for addressing illness experience issues with patients Figure 3
Recommendations for addressing illness experience issues with patients.
-  Acknowledge the uniqueness of the disease 
-  Be as honest and forthright as possible 
-  When discussing treatment, ask patients what they value 
-  Discuss the risks of surgery openly and plainly 
-  Ask patients if they’d like to speak to someone regarding their spiritual or 
religious beliefs, if present 
-  Arrange a social work consultation if patients are having difficulty coping
-  Screen for the warning signs of depression BMC Palliative Care 2007, 6:7 http://www.biomedcentral.com/1472-684X/6/7
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